Shares of Threshold Pharmaceuticals (THLD) surge another 6.7% premarket off of news of its...

|About: Threshold Pharmaceuticals... (THLD)|By:, SA News Editor

Shares of Threshold Pharmaceuticals (THLD) surge another 6.7% premarket off of news of its mega-deal with Merck KGaA announced on Friday to co-develop and commercialize its TH-302 cancer treatment drug. The deal calls for the company to receive $25M up front and another $525M down the line from Merck.